Company profile for Beyond Cancer

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The management team has deep experience in oncology as well as the safe and effective delivery of nitric oxide–based therapy. Chief Executive Officer Selena Chaisson, MD, brings unparalleled management experience from the finance sector, including 15 years as Director of Healthcare Investments at Bailard, Inc. In addition, they will leverage the expertise at Beyond Air which has already proven the ability to safely harness t...
The management team has deep experience in oncology as well as the safe and effective delivery of nitric oxide–based therapy. Chief Executive Officer Selena Chaisson, MD, brings unparalleled management experience from the finance sector, including 15 years as Director of Healthcare Investments at Bailard, Inc. In addition, they will leverage the expertise at Beyond Air which has already proven the ability to safely harness the power of nitric oxide to treat respiratory disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
900 Stewart Ave Suite 301 Garden City, NY 11530
Telephone
Telephone
+1-516-665-8200
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.indianpharmapost.com/news/paras-health-gurugram-raises-alarm-over-surge-in-tobacco-related-cancers-17225

INDPHARMAPOST
31 May 2025

https://www.globenewswire.com/news-release/2024/12/03/2991054/0/en/Beyond-Cancer-Announces-Approval-by-the-Israeli-Ministry-of-Health-to-Conduct-a-Phase-1b-Clinical-Trial-Utilizing-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-in-Combina.html

GLOBENEWSWIRE
03 Dec 2024

https://www.globenewswire.com/news-release/2024/11/11/2978200/0/en/Beyond-Cancer-Presents-Promising-Preclinical-Data-on-Low-Volume-Ultra-High-Concentration-Nitric-Oxide-LV-UNO-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Mee.html

GLOBENEWSWIRE
11 Nov 2024

https://www.globenewswire.com/news-release/2024/10/07/2958798/0/en/Beyond-Cancer-to-Present-Preclinical-Data-of-Ultra-High-Concentration-Nitric-Oxide-UNO-Low-Volume-Therapy-at-the-2024-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html

GLOBENEWSWIRE
07 Oct 2024

https://www.globenewswire.com/news-release/2024/05/01/2873103/0/en/Beyond-Cancer-Selected-to-Present-on-the-Clinical-Development-of-Ultra-High-Concentration-Nitric-Oxide-UNO-Therapy-at-the-2024-American-Society-of-Clinical-Oncology-Annual-Meeting.html

GLOBENEWSWIRE
01 May 2024

https://www.globenewswire.com/news-release/2022/12/13/2572889/0/en/Beyond-Cancer-Publishes-Pre-Clinical-Data-in-Cancer-Cell-International-Demonstrating-Its-Tumor-Ablation-Method-Utilizing-Ultra-High-Concentration-Nitric-Oxide-UNO-Induced-a-Systemi.html

GLOBENEWSWIRE
13 Dec 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty